Hayashi, Masatoshi <br/><br/>
Effect of total arthroplasty combined with anti-tumor necrosis factor agents in attenuating systemic disease activity in patients with rheumatoid arthritis.  [electronic resource] 

 -  Modern rheumatology  Jun 2012 
 - 363-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1439-7609 
<br/><br/><label>Standard No.: </label>10.1007/s10165-011-0527-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--drug therapy<br/>Arthroplasty, Replacement<br/>Combined Modality Therapy<br/>Etanercept<br/>Female<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Severity of Illness Index<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors